Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Dominari Holdings - 45 Year Stock Price History | DOMH

Historical daily share price chart and data for Dominari Holdings since 1980 adjusted for splits and dividends. The latest closing stock price for Dominari Holdings as of August 26, 2025 is 6.39.
  • The all-time high Dominari Holdings stock closing price was 960976.00 on May 28, 1986.
  • The Dominari Holdings 52-week high stock price is 13.58, which is 112.5% above the current share price.
  • The Dominari Holdings 52-week low stock price is 0.83, which is 87% below the current share price.
  • The average Dominari Holdings stock price for the last 52 weeks is 3.84.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Dominari Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 4.9411 1.0475 12.4927 0.9898 6.3900 578.49%
2024 1.9145 2.4505 3.0175 0.8649 0.9418 -62.16%
2023 2.8188 3.3250 4.2763 1.7778 2.4889 -21.04%
2022 5.9378 10.1287 10.1287 2.9502 3.1520 -67.30%
2021 15.9632 14.2128 38.3910 9.4752 9.6386 -32.18%
2020 13.4141 22.8712 52.6038 8.0049 14.2128 -34.09%
2019 37.7166 45.5954 57.4627 17.1534 21.5643 -46.05%
2018 67.4587 86.1940 125.5440 35.6019 39.9741 -54.29%
2017 85.0345 63.7086 244.8410 56.8382 87.4432 34.62%
2016 112.4643 142.4080 191.7510 54.3397 64.9578 -63.51%
2015 668.3361 1281.6700 1341.0000 166.1420 178.0100 -86.11%
2014 3013.8230 10324.5000 10324.5000 961.2510 1281.6700 -86.60%
2013 9877.0303 8093.5000 25752.0000 5067.3400 9565.0400 18.01%
2012 16345.1614 28956.2000 34177.8000 7701.8800 8105.3600 -70.81%
2011 72130.5659 180383.0000 232599.0000 27769.5000 27769.5000 -83.52%
2010 289769.2579 282442.0000 436717.0000 125793.0000 168516.0000 -37.72%
2009 279804.5056 118673.0000 531655.0000 59336.5000 270574.0000 147.83%
2008 188385.1336 284815.0000 306176.0000 47469.2000 109179.0000 -58.56%
2007 471732.2032 503173.0000 674062.0000 263454.0000 263454.0000 -51.10%
2006 484620.7410 790362.0000 842578.0000 284815.0000 538775.0000 -34.20%
2005 555133.0952 806976.0000 960976.0000 284815.0000 818844.0000 6.15%
2004 903298.3810 960976.0000 960976.0000 640834.0000 771374.0000 -19.73%
2003 960976.0000 960976.0000 960976.0000 960976.0000 960976.0000 0.00%
2002 960600.3532 960976.0000 960976.0000 866313.0000 960976.0000 0.00%
2001 960976.0000 960976.0000 960976.0000 960976.0000 960976.0000 0.00%
2000 960976.0000 960976.0000 960976.0000 960976.0000 960976.0000 0.00%
1999 960959.4325 960976.0000 960976.0000 956801.0000 960976.0000 0.00%
1998 953850.9603 960976.0000 960976.0000 786208.0000 960976.0000 0.00%
1997 958412.4664 960976.0000 960976.0000 845545.0000 960976.0000 0.00%
1996 960976.0000 960976.0000 960976.0000 960976.0000 960976.0000 0.00%
1995 790052.2976 563697.0000 960976.0000 504360.0000 960976.0000 61.95%
1994 772433.9603 919716.0000 949384.0000 563697.0000 593365.0000 -33.33%
1993 793296.1146 960976.0000 960976.0000 534028.0000 890047.0000 11.11%
1992 878377.0079 608199.0000 960976.0000 608199.0000 801043.0000 28.57%
1991 707353.2767 192844.0000 960976.0000 163175.0000 623033.0000 250.00%
1990 462613.6047 585948.0000 637867.0000 178009.0000 178009.0000 -68.42%
1989 554484.2262 652701.0000 741706.0000 385687.0000 563697.0000 -13.64%
1988 864651.5771 960976.0000 960976.0000 593365.0000 652701.0000 -32.08%
1987 909965.8458 771374.0000 960976.0000 623033.0000 960976.0000 24.58%
1986 762118.1146 504360.0000 960976.0000 504360.0000 771374.0000 52.94%
1985 351074.1825 326351.0000 712038.0000 237346.0000 504360.0000 54.55%
1984 407029.4348 356019.0000 593365.0000 296682.0000 326351.0000 -8.33%
1983 578296.2688 445024.0000 830711.0000 326351.0000 356019.0000 -20.00%
1982 528165.1067 445024.0000 726872.0000 385687.0000 445024.0000 -3.23%
1981 400741.1462 155758.0000 830711.0000 133507.0000 459858.0000 195.24%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.096B $0.018B
Dominari Holdings Inc. primarily focused on the development of a diverse portfolio of small-molecule anticancer and antiviral therapeutics and related patent technology. The Company's fintech and financial services business will be operated through its subsidiary, Dominari Financial Inc. Dominari Holdings Inc., formerly known as AIkido Pharma Inc., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.778B 24.95
Chugai Pharmaceutical (CHGCY) Japan $68.684B 26.42
Takeda Pharmaceutical (TAK) Japan $47.952B 9.79
Daiichi Sankyo, - (DSNKY) Japan $47.757B 24.48
BeOne Medicines - (ONC) Switzerland $33.826B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.575B 0.00
Summit Therapeutics (SMMT) United States $19.515B 0.00
Merck (MKKGY) Germany $16.543B 10.76
Shionogi (SGIOY) Japan $14.700B 14.73
United Therapeutics (UTHR) United States $13.775B 11.92
Neurocrine Biosciences (NBIX) United States $13.289B 39.64
IPSEN (IPSEY) France $11.429B 0.00
Orion OYJ (ORINY) Finland $11.336B 27.32
Eisai (ESAIY) $9.228B 10.41
Madrigal Pharmaceuticals (MDGL) United States $9.153B 0.00
Corcept Therapeutics (CORT) United States $7.252B 60.90
Grifols, S.A (GRFS) Spain $6.752B 0.00
Ionis Pharmaceuticals (IONS) United States $6.666B 0.00
Stevanato Group S.p.A (STVN) Italy $6.660B 39.27
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) United States $3.535B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.915B 13.85
Crinetics Pharmaceuticals (CRNX) United States $2.834B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.782B 0.00
Hypermarcas (HYPMY) Brazil $2.755B 20.71
Catalyst Pharmaceuticals (CPRX) United States $2.524B 8.45
Procaps Group, S.A (PROCF) Luxembourg $2.419B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.277B 0.00
Ocular Therapeutix (OCUL) United States $2.065B 0.00
Dyne Therapeutics (DYN) United States $1.849B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.761B 0.00
Guardian Pharmacy Services (GRDN) United States $1.661B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.597B 23.79
Ardelyx (ARDX) United States $1.460B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.438B 0.00
Harrow (HROW) United States $1.382B 0.00
ARS Pharmaceuticals (SPRY) United States $1.335B 0.00
Evotec AG (EVO) Germany $1.268B 0.00
Xeris Biopharma Holdings (XERS) United States $1.255B 0.00
Collegium Pharmaceutical (COLL) United States $1.221B 6.67
Enliven Therapeutics (ELVN) United States $1.181B 0.00
Cronos Group (CRON) Canada $0.992B 0.00
Akebia Therapeutics (AKBA) United States $0.803B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.758B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.731B 7.53
Theravance Biopharma (TBPH) United States $0.695B 57.48
ProKidney (PROK) United States $0.692B 0.00
KalVista Pharmaceuticals (KALV) United States $0.654B 0.00
Siga Technologies (SIGA) United States $0.623B 7.70
Bioventus (BVS) United States $0.615B 14.88
Relay Therapeutics (RLAY) United States $0.605B 0.00
Elite Pharmaceuticals (ELTP) United States $0.594B 0.00
Organogenesis (ORGO) United States $0.592B 0.00
Tourmaline Bio (TRML) United States $0.583B 0.00
USANA Health Sciences (USNA) United States $0.581B 11.91
Xencor (XNCR) United States $0.571B 0.00
Oruka Therapeutics (ORKA) United States $0.543B 0.00
Savara (SVRA) United States $0.543B 0.00
Zevra Therapeutics (ZVRA) United States $0.525B 0.00
Nektar Therapeutics (NKTR) United States $0.516B 0.00
Nanobiotix S.A (NBTX) France $0.472B 0.00
Esperion Therapeutics (ESPR) United States $0.433B 0.00
Aquestive Therapeutics (AQST) United States $0.385B 0.00
Aldeyra Therapeutics (ALDX) United States $0.346B 0.00
4D Molecular Therapeutics (FDMT) United States $0.315B 0.00
Larimar Therapeutics (LRMR) United States $0.308B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.303B 0.00
Altimmune (ALT) United States $0.299B 0.00
AleAnna (ANNA) United States $0.294B 0.00
Nature's Sunshine Products (NATR) United States $0.293B 19.07
Galectin Therapeutics (GALT) United States $0.256B 0.00
Lexeo Therapeutics (LXEO) United States $0.252B 0.00
Heron Therapeutics (HRTX) United States $0.212B 0.00
Lyell Immunopharma (LYEL) United States $0.211B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.206B 31.75
OmniAb (OABI) United States $0.200B 0.00
Aclaris Therapeutics (ACRS) United States $0.195B 0.00
Korro Bio (KRRO) United States $0.188B 0.00
MediWound (MDWD) Israel $0.186B 0.00
Journey Medical (DERM) United States $0.180B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
China SXT Pharmaceuticals (SXTC) China $0.172B 0.00
Achieve Life Sciences (ACHV) Canada $0.169B 0.00
MEI Pharma (MEIP) United States $0.162B 0.00
Profound Medical (PROF) Canada $0.140B 0.00
Wellgistics Health (WGRX) United States $0.138B 0.00
Inhibikase Therapeutics (IKT) United States $0.131B 0.00
Avita Medical (RCEL) United States $0.124B 0.00
Avalo Therapeutics (AVTX) United States $0.124B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.121B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Surrozen (SRZN) United States $0.099B 0.00
Champions Oncology (CSBR) United States $0.097B 22.06
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
Liminatus Pharma (LIMN) United States $0.088B 0.00
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Pyxis Oncology (PYXS) United States $0.086B 0.00
VAXART, INC (VXRT) United States $0.081B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Arch Biopartners (ACHFF) Canada $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.073B 0.00
Prelude Therapeutics (PRLD) United States $0.072B 0.00
Nutriband (NTRB) United States $0.071B 0.00
Metagenomi (MGX) United States $0.071B 0.00
Gain Therapeutics (GANX) United States $0.066B 0.00
DURECT (DRRX) United States $0.060B 0.00
Inotiv (NOTV) United States $0.060B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Karyopharm Therapeutics (KPTI) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.053B 0.00
Rafael Holdings (RFL) United States $0.052B 0.00
Fractyl Health (GUTS) United States $0.050B 0.00
Jupiter Neurosciences (JUNS) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.64
Plus Therapeutics (PSTV) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
Tempest Therapeutics (TPST) United States $0.047B 0.00
Klotho Neurosciences (KLTO) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.044B 0.00
FibroGen (FGEN) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
ESSA Pharma (EPIX) Canada $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Incannex Healthcare (IXHL) Australia $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Ainos (AIMD) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Mangoceuticals (MGRX) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Vyome Holdings (HIND) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
CDT Equity (CDT) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.49
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.61
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00